摘要
Abstract
Objective To investigate the efficacy and safety of Xiaoqinglongtang in treatment for bronchial asthma patients with acute exacerbation.Methods 105 cases of bronchial asthma with acute exacerbation were selected from our hospital,they were randomly divided into control group (53 cases),given conventional Western treatment,research group (52 cases),given routine western treatment and Xiaoqinglongtang therapy.The effects,peak expiratory flow (PEF),and the eosinophil (EOS) concentration and adverse reaction rate of two groups after 14 days of treatment were compared.Results Treatment efficiency of research group (88.46％) was significantly higher than that in the control group (75.47％) (P＜0.05),the effectual time of research group (5.7 ± 0.9) days was significantly shorter than that of control group (7.1 ± 1.3) days (P＜0.05),after treatment,PEF of research group was significantly higher compared with that before treatmeut [60.35 ± 2.71) ％ vs (81.69 ± 2.63) ％],and the EOS was lower compared with that before treatment [(481.2 ± 151.59) × 106/L vs(311.8 ± 53.65) × 106/L],with significant difference (P＜0.05).Conclusion Bronchial asthma patients with acute exacerbation treated with Western medicine and the Xiaoqinglongtang therapy can significantly improve treatment effect,with better improvements in lung function,and also with good results on the EOS level reducing,without increasing the incidence of adverse reactions in patients,which can be applied in clinical practice.关键词
支气管哮喘/急性发作/小青龙汤/安全性Key words
Bronchial asthma/Acute attack/Xiaoqinglongtang/Safety
